i'm lauren becker with the global health technologies coalition. i'm very curious, for the second set of recommendations, the u.s. government were very clear actors, and for some of the first set there were as well, but i'm curious because, um, as we all know the challenges in developing country regulators, they're not waiting for an iom report to tell them that they should communicate more with each other, but they clearly need to. so i'm wondering as who you see as sort of a driving force particularly for that recommendation, but for the other international recommendations as well? >> essentially, what we're looking at is, again, the agendas, bring it on the g20 agendas to get the u.s. and other areas on the development organizations and the world bank and various other groups to, essentially, put strengthening regulatory infrastructure as a priority in anything going forward, to start getting that message out. so our tie-in with the domestic regulations at fda bring this forward, and the question on congress. bring this forward as new approaches